Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosusJing He, Zhanguo Li, Yaping Chen et al.|Nature Medicine|2016Cited by 570
CD28 Homodimer Interface Mimetic Peptide Acts as a Preventive and Therapeutic Agent in Models of Severe Bacterial Sepsis and Gram-Negative Bacterial PeritonitisGirish Ramachandran, Steven M. Opal, Raymond Kaempfer et al.|The Journal of Infectious Diseases|2014Cited by 41